VC008

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameVC008
Drug Alias NameVC-008
ClassificationSmall molecules
Mechanisms of ActionV-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog inhibitors
TargetsGTPase KRas
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesJiangsu Vcare Pharmatech Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesJiangsu Vcare Pharmatech Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A